Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

FDA Considers New Approach to Improve Safe Disposal of Prescription Opioid Analgesics, Decrease Unnecessary Exposure to Unused Medication

Posted 4/20/2022

April 20, 2022 - The U.S. Food and Drug Administration announced it is seeking public comment on a potential change that would require opioid analgesics used in outpatient settings to be dispensed with prepaid mail-back envelopes and that pharmacists provide patient education on safe disposal of opioids. This potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy would provide a convenient, additional disposal option for patients beyond those already available such as flushing, commercially available in-home disposal products, collection kiosks and takeback events. 

The FDA is accepting public comments from interested parties, including patients, patient advocates, health care professionals, academics, researchers, the pharmaceutical industry and other government entities until June 21, 2022; however, comments are welcome at any time. 

External Reference: https://www.fda.gov/news-events/press-announcements/fda-considers-new-approach-improve-safe-disposal-prescription-opioid-analgesics-decrease-unnecessary

Back to all news

Sponsor Spotlight


RxGov by Tyler Technologies
RxGov is a leading Prescription Monitoring Platform (PMP) that improves access to clinical data pertinent to a patient's medication history and the risk factors associated with substance use disorder through the capture, analysis, proactive monitoring, and open sharing of a state's prescription dispense details.

The system is one of the most interoperable, integrated and intuitive on the market. It also includes complete oversight and compliance with the state's current PDMP system, including statewide mandates. RxGov allows the PDMP administrator unprecedented access to insightful data sets, such as query history and compliance reports at all levels: state, region, organization, and individual prescriber. Freely accessible data, enhanced by useful visualization tools, is central to RxGov.

To learn more about RxGov and how the platform can help state governments fight the opioid crisis, email rxgov@egov.com or download our one pager.

All Sponsors